Transcriptome Analysis Identifies a Myeloid‐Like Signature in Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy
Shisen Wang, Wenbing Liu, Ying Wang, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Shaowei Qiu, Hui Wei, Runxia Gu, Min Wang, Jianxiang Wang · 2026
Read Transcriptome Analysis Identifies a Myeloid‐Like Signature in Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy by Shisen Wang, Wenbing Liu, Ying Wang, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Shaowei Qiu, Hui Wei, Runxia Gu, Min Wang, Jianxiang Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13680287.txt.
Description
Shisen Wang and co-authors look for gene signs of poor response to cell therapy in leukemia in a 2026 study. Patients with relapsed B-cell acute lymphoblastic leukemia respond in unlike ways to CD19 CAR-T therapy. Most past work studies the therapy cells or the blasts. What the patient's own marrow shows before treatment is less known.
Fifteen trial patients split into eight good and seven poor responders at three months. Poor responders show a myeloid-like gene pattern in marrow taken before treatment, the team finds. A seven-gene score splits the groups in this small set, but checks in outside groups give much weaker scores. More testing is needed.
Catalog record
| CREATOR | Shisen Wang, Wenbing Liu, Ying Wang, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Shaowei Qiu, Hui Wei, Runxia Gu, Min Wang, Jianxiang Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |